Published in Brain Res Bull on February 01, 1990
Central angiotensin (1-7) enhances baroreflex gain in conscious rabbits with heart failure. Hypertension (2011) 0.95
An evolving story of angiotensin-II-forming pathways in rodents and humans. Clin Sci (Lond) (2014) 0.93
Inhibition of early atherogenesis by losartan in monkeys with diet-induced hypercholesterolemia. Circulation (2000) 1.93
Effects of captopril related to increased levels of prostacyclin and angiotensin-(1-7) in essential hypertension. J Hypertens (1996) 1.73
Local circuit synaptic interactions in hippocampal brain slices. J Neurosci (1981) 1.72
Hypertension-related morbidity and mortality in the southeastern United States. Am J Med Sci (1997) 1.71
Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide. Hypertension (1996) 1.48
Differential actions of renal ischemic injury on the intrarenal angiotensin system. Am J Physiol Renal Physiol (2000) 1.45
Pathways for angiotensin-(1---7) metabolism in pulmonary and renal tissues. Am J Physiol Renal Physiol (2000) 1.45
Effects of vascular stent surface area and hemodynamics on intimal thickening. J Vasc Interv Radiol (1996) 1.43
Assessment of parasympathetic control of heart rate by a noninvasive method. Am J Physiol (1984) 1.41
Angiotensin-(1-7) inhibits vascular smooth muscle cell growth. Hypertension (1996) 1.40
In vivo metabolism of angiotensin I by neutral endopeptidase (EC 3.4.24.11) in spontaneously hypertensive rats. Hypertension (1992) 1.31
A comparison of the properties and enzymatic activities of three angiotensin processing enzymes: angiotensin converting enzyme, prolyl endopeptidase and neutral endopeptidase 24.11. Life Sci (1993) 1.31
Vasodepressor actions of angiotensin-(1-7) unmasked during combined treatment with lisinopril and losartan. Hypertension (1998) 1.29
Angiotensin II acts at AT1 receptors in the nucleus of the solitary tract to attenuate the baroreceptor reflex. Am J Physiol (1998) 1.28
Antihypertensive actions of angiotensin-(1-7) in spontaneously hypertensive rats. Am J Physiol (1995) 1.27
Increased expression of angiotensin peptides in the brain of transgenic hypertensive rats. Peptides (1994) 1.26
Initial coronary air embolus in the differential diagnosis of coronary artery spasm. Am J Cardiol (1985) 1.24
Identification of angiotensin-(1-7) in rat brain. Evidence for differential processing of angiotensin peptides. J Biol Chem (1989) 1.23
Pathophysiology of intravenous air embolism in dogs. Anesthesiology (1978) 1.22
Estrogen protects transgenic hypertensive rats by shifting the vasoconstrictor-vasodilator balance of RAS. Am J Physiol (1997) 1.21
Metabolism of angiotensin-(1-7) by angiotensin-converting enzyme. Hypertension (1998) 1.21
Angiotensin-(1-7) contributes to the antihypertensive effects of blockade of the renin-angiotensin system. Hypertension (1998) 1.19
State-of-the-Art lecture. Antiproliferative actions of angiotensin-(1-7) in vascular smooth muscle. Hypertension (1999) 1.18
Cardiovascular effects of angiotensin-(1-7) injected into the dorsal medulla of rats. Am J Physiol (1989) 1.16
Angiotensin-(1-7) augments bradykinin-induced vasodilation by competing with ACE and releasing nitric oxide. Hypertension (1997) 1.16
Release of vasopressin from the rat hypothalamo-neurohypophysial system by angiotensin-(1-7) heptapeptide. Proc Natl Acad Sci U S A (1988) 1.13
Baroreceptor reflex modulation by angiotensin II at the nucleus tractus solitarii. Hypertension (1988) 1.12
Converting enzyme determines plasma clearance of angiotensin-(1-7). Hypertension (1998) 1.11
Angiotensin-(1-7) reduces smooth muscle growth after vascular injury. Hypertension (1999) 1.11
Cardiovascular actions of angiotensin(1-7). Peptides (1993) 1.11
Renal actions of angiotensin-(1-7): in vivo and in vitro studies. Am J Physiol (1996) 1.11
Reassessment of plasma angiotensins measurement: effects of protease inhibitors and sample handling procedures. Peptides (1992) 1.11
Losartan, nonpeptide angiotensin II-type 1 (AT1) receptor antagonist, attenuates pressor and sympathoexcitatory responses evoked by angiotensin II and L-glutamate in rostral ventrolateral medulla. Brain Res (1994) 1.08
Opposing actions of angiotensin-(1-7) and angiotensin II in the brain of transgenic hypertensive rats. Hypertension (1995) 1.06
Distribution of angiotensin-(1-7) and ACE2 in human placentas of normal and pathological pregnancies. Placenta (2005) 1.05
Simulation of hippocampal afterdischarges synchronized by electrical interactions. Neuroscience (1985) 1.05
Cardiovascular effects of angiotensin mediated by the central nervous system. Circ Res (1972) 1.04
Angiotensin-(1-7) and nitric oxide interaction in renovascular hypertension. Hypertension (1995) 1.04
Temporal-spatial expression of ANG-(1-7) and angiotensin-converting enzyme 2 in the kidney of normal and hypertensive pregnant rats. Am J Physiol Regul Integr Comp Physiol (2007) 1.04
Production of angiotensin-(1-7) by human vascular endothelium. Hypertension (1992) 1.03
Benefits of adherence to anti-hypertensive drug therapy. Eur Heart J (1996) 1.03
Axonal ramifications of hippocampal Ca1 pyramidal cells. J Neurosci (1981) 1.02
Angiotensin-(1-7). A member of circulating angiotensin peptides. Hypertension (1991) 1.02
Evidence that prostaglandins mediate the antihypertensive actions of angiotensin-(1-7) during chronic blockade of the renin-angiotensin system. J Cardiovasc Pharmacol (2000) 1.00
Pressor and reflex sensitivity is altered in spontaneously hypertensive rats treated with angiotensin-(1-7). Hypertension (1995) 1.00
Evidence for an intrinsic angiotensin system in the canine pancreas. J Hypertens (1991) 0.99
Models of the cellular mechanism underlying propagation of epileptiform activity in the CA2-CA3 region of the hippocampal slice. Neuroscience (1987) 0.98
Bi-directional actions of estrogen on the renin-angiotensin system. Braz J Med Biol Res (1999) 0.97
Computer simulations indicate that electrical field effects contribute to the shape of the epileptiform field potential. Neuroscience (1985) 0.96
Bovine aortic endothelial cells contain an angiotensin-(1-7) receptor. Hypertension (1997) 0.96
Release of angiotensin-(1-7) from the rat hindlimb: influence of angiotensin-converting enzyme inhibition. Hypertension (2000) 0.95
Effect of angiotensin II in ventrolateral medulla of spontaneously hypertensive rats. Am J Physiol (1991) 0.94
Central vasomotor stimulation by angiotensin. Clin Sci (1970) 0.94
Intracellular study of human epileptic cortex: in vitro maintenance of epileptiform activity? Science (1984) 0.93
Converting enzyme activity and angiotensin metabolism in the dog brainstem. Hypertension (1988) 0.92
Sexual dysfunction in hypertensive patients treated with losartan. Am J Med Sci (2001) 0.92
Mechanisms of hypertension in transgenic rats expressing the mouse Ren-2 gene. Am J Physiol (1994) 0.92
Association of angiotensinogen M235T and A(-6)G gene polymorphisms with coronary heart disease with independence of essential hypertension: the PROCAGENE study. Prospective Cardiac Gene. J Am Coll Cardiol (2001) 0.92
Angiotensin-converting enzyme expression in human carotid artery atherosclerosis. Hypertension (2000) 0.92
Contribution of angiotensin-(1-7) to blood pressure regulation in salt-depleted hypertensive rats. Hypertension (2000) 0.91
Evidence that prolyl endopeptidase participates in the processing of brain angiotensin. J Hypertens (1991) 0.91
Cardiac performance in rats with renal hypertension. Circ Res (1976) 0.91
Urinary vasodilator and vasoconstrictor angiotensins during menstrual cycle, pregnancy, and lactation. Endocrine (2001) 0.90
The initiation and spread of epileptiform bursts in the in vitro hippocampal slice. Neuroscience (1987) 0.90
Pathways of angiotensin-(1-7) metabolism in the kidney. Nephrol Dial Transplant (2001) 0.90
Angiotensin-(1-7) immunoreactivity in the hypothalamus of the (mRen-2d)27 transgenic rat. Brain Res (1998) 0.90
Angiotensin II receptor subtypes in the human renal cortex and renal cell carcinoma. J Urol (1994) 0.89
Subtype 2 angiotensin receptors mediate prostaglandin synthesis in human astrocytes. Hypertension (1991) 0.89
Flow velocity variations in the pulmonary veins of the dog. Invest Radiol (1968) 0.89
Role of nitric oxide and angiotensin II in the regulation of sympathetic nerve activity in spontaneously hypertensive rats. Hypertension (1993) 0.88
Angiotensin-(1-7): a novel vasodilator of the coronary circulation. Biol Res (1998) 0.88
Studies of human and monkey "epileptic" neocortex in the in vitro slice preparation. Ann Neurol (1983) 0.88
Angiotensin II receptor localization in the canine CNS. Brain Res (1985) 0.87
Losartan inhibits thromboxane A2-induced platelet aggregation and vascular constriction in spontaneously hypertensive rats. J Cardiovasc Pharmacol (1998) 0.87
Angiotensin(1-7) in the spontaneously hypertensive rat. Peptides (1994) 0.87
Using angiotensin converting enzyme inhibitors in African-American hypertensives: a new approach to treating hypertension and preventing target-organ damage. Curr Med Res Opin (2000) 0.87
Astrocyte cultures derived from human brain tissue express angiotensinogen mRNA. Proc Natl Acad Sci U S A (1990) 0.87
Mechanism of systemic vasodilation during normovolemic hemodilution. Anesth Analg (1995) 0.86
Neurogenic actions of angiotensin II. Hypertension (1984) 0.86
Differential response of angiotensin peptides in the urine of hypertensive animals. Regul Pept (1999) 0.86
Angiotensin-(1-7) serves as an aquaretic by increasing water intake and diuresis in association with downregulation of aquaporin-1 during pregnancy in rats. Am J Physiol Regul Integr Comp Physiol (2008) 0.85
Lymphoid alterations and impaired T lymphocyte reactivity in experimental renal hypertension. J Lab Clin Med (1980) 0.85
Estrogen augments the contribution of nitric oxide to blood pressure regulation in transgenic hypertensive rats expressing the mouse Ren-2 gene. Am J Hypertens (1994) 0.85
Physiological and pharmacological characterization of the area postrema pressor pathways in the normal dog. Hypertension (1980) 0.85
Differential regulation of prostaglandin synthesis by angiotensin peptides in porcine aortic smooth muscle cells: subtypes of angiotensin receptors involved. J Pharmacol Exp Ther (1993) 0.85
Identification and regulation of angiotensin II receptor subtypes on NG108-15 cells. Hypertension (1991) 0.84
Immunocytochemical localization of angiotensin-(1-7) in the rat forebrain. Peptides (1989) 0.84
Neurogenic hypertension produced by lesions of the nucleus tractus solitarii alone or with sinoaortic denervation in the dog. Hypertension (1982) 0.84
Role of paraventricular angiotensin AT1 receptors in salt-sensitive hypertension in mRen-2 transgenic rats. Am J Physiol (1996) 0.84
Inhibition of angiotensin converting enzyme by the metalloendopeptidase 3.4.24.15 inhibitor c-phenylpropyl-alanyl-alanyl-phenylalanyl-p-aminobenzoate. Peptides (1993) 0.84
Differential regulation of central vasopressin in transgenic rats harboring the mouse Ren-2 gene. Am J Physiol (1994) 0.84
Magnetic resonance of brain tumors: considerations of imaging contrast on the basis of relaxation measurements. Magn Reson Imaging (1985) 0.83
Selective blockade of angiotensin responses in the rabbit isolated vas deferens by angiotensin receptor antagonists. J Pharmacol Exp Ther (1990) 0.83
Actions of angiotensin peptides after partial denervation of the solitary tract nucleus. Hypertension (1990) 0.83
Synchronized afterdischarges in the hippocampus: simulation studies of the cellular mechanism. Neuroscience (1984) 0.83
Current views concerning cardiac output in the genesis of experimental hypertension. Circ Res (1978) 0.83
Contribution of the vagus nerve to angiotensin II binding sites in the canine medulla. Brain Res Bull (1986) 0.83
Role of area postrema in transgene hypertension. Hypertension (1996) 0.82
Hemodynamic characteristics of chronic experimental neurogenic hypertension in unanesthetized dogs. Circ Res (1969) 0.82
Novel mechanisms linking angiotensin II and early atherogenesis. J Renin Angiotensin Aldosterone Syst (2000) 0.82